Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

Daniel K. Benjamin, Barbara J. Stoll, Avory A. Fanaroff, Scott A. McDonald, William Oh, Rosemary D. Higgins, Shahnaz Duara, Kenneth Poole, Abbot Laptook, Ronald Goldberg

Research output: Contribution to journalArticle

404 Citations (Scopus)

Abstract

BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported. METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death. RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7%) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48%) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10% of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73% of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly. CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

Original languageEnglish
Pages (from-to)84-92
Number of pages9
JournalPediatrics
Volume117
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Extremely Low Birth Weight Infant
Candidiasis
Catheters
Mortality
Candida
Meningitis
Newborn Infant
Morbidity
Therapeutics
Blood Culture

Keywords

  • Candidiasis
  • Culture
  • Meningitis
  • Prematureinfant
  • Sensitivity
  • Specificity

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Benjamin, D. K., Stoll, B. J., Fanaroff, A. A., McDonald, S. A., Oh, W., Higgins, R. D., ... Goldberg, R. (2006). Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics, 117(1), 84-92. https://doi.org/10.1542/peds.2004-2292

Neonatal candidiasis among extremely low birth weight infants : Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. / Benjamin, Daniel K.; Stoll, Barbara J.; Fanaroff, Avory A.; McDonald, Scott A.; Oh, William; Higgins, Rosemary D.; Duara, Shahnaz; Poole, Kenneth; Laptook, Abbot; Goldberg, Ronald.

In: Pediatrics, Vol. 117, No. 1, 01.01.2006, p. 84-92.

Research output: Contribution to journalArticle

Benjamin, DK, Stoll, BJ, Fanaroff, AA, McDonald, SA, Oh, W, Higgins, RD, Duara, S, Poole, K, Laptook, A & Goldberg, R 2006, 'Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months', Pediatrics, vol. 117, no. 1, pp. 84-92. https://doi.org/10.1542/peds.2004-2292
Benjamin, Daniel K. ; Stoll, Barbara J. ; Fanaroff, Avory A. ; McDonald, Scott A. ; Oh, William ; Higgins, Rosemary D. ; Duara, Shahnaz ; Poole, Kenneth ; Laptook, Abbot ; Goldberg, Ronald. / Neonatal candidiasis among extremely low birth weight infants : Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. In: Pediatrics. 2006 ; Vol. 117, No. 1. pp. 84-92.
@article{5532753eec924acca3c38e2ad387aa53,
title = "Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months",
abstract = "BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported. METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death. RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7{\%}) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48{\%}) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10{\%} of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73{\%} of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly. CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.",
keywords = "Candidiasis, Culture, Meningitis, Prematureinfant, Sensitivity, Specificity",
author = "Benjamin, {Daniel K.} and Stoll, {Barbara J.} and Fanaroff, {Avory A.} and McDonald, {Scott A.} and William Oh and Higgins, {Rosemary D.} and Shahnaz Duara and Kenneth Poole and Abbot Laptook and Ronald Goldberg",
year = "2006",
month = "1",
day = "1",
doi = "10.1542/peds.2004-2292",
language = "English",
volume = "117",
pages = "84--92",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Neonatal candidiasis among extremely low birth weight infants

T2 - Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months

AU - Benjamin, Daniel K.

AU - Stoll, Barbara J.

AU - Fanaroff, Avory A.

AU - McDonald, Scott A.

AU - Oh, William

AU - Higgins, Rosemary D.

AU - Duara, Shahnaz

AU - Poole, Kenneth

AU - Laptook, Abbot

AU - Goldberg, Ronald

PY - 2006/1/1

Y1 - 2006/1/1

N2 - BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported. METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death. RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7%) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48%) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10% of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73% of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly. CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

AB - BACKGROUND. Neonatal candidiasis is associated with substantial morbidity and mortality rates. Neurodevelopmental follow-up data for a large multicenter cohort have not been reported. METHODS. Data were collected prospectively for neonates born at <1000 g at National Institute of Child Health and Human Development-sponsored Neonatal Research Network sites between September 1, 1998, and December 31, 2001. Uniform follow-up evaluations, including assessments of mental and motor development with the Bayley Scales of Infant Development II, were completed for all survivors at corrected ages of 18 to 22 months. We evaluated risk factors for the development of neonatal candidiasis, responses to antifungal therapy, and the association between candidiasis and subsequent morbidity and death. RESULTS. The cohort consisted of 4579 infants; 320 of 4579 (7%) developed candidiasis; 307 of 320 had Candida isolated from blood, 27 of 320 had Candida isolated from cerebrospinal fluid, and 13 (48%) of 27 of those with meningitis had negative blood cultures. In multivariate analysis of risk factors on day of life 3, birth weight, cephalosporins, gender, and lack of enteral feeding were associated with development of candidiasis. After diagnosis, most neonates had multiple positive cultures despite antifungal therapy, and 10% of neonates had candidemia for ≥14 days. Death or neurodevelopmental impairment (NDI) was observed for 73% of extremely low birth weight infants who developed candidiasis. Death and NDI rates were greater for infants who had delayed removal or replacement of central catheters (>1 day after initiation of antifungal therapy), compared with infants whose catheters were removed or replaced promptly. CONCLUSIONS. Blood cultures were negative for approximately one half of the infants with Candida meningitis. Persistent candidiasis was common. Delayed catheter removal was associated with increased death and NDI rates.

KW - Candidiasis

KW - Culture

KW - Meningitis

KW - Prematureinfant

KW - Sensitivity

KW - Specificity

UR - http://www.scopus.com/inward/record.url?scp=33644836691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644836691&partnerID=8YFLogxK

U2 - 10.1542/peds.2004-2292

DO - 10.1542/peds.2004-2292

M3 - Article

C2 - 16396864

AN - SCOPUS:33644836691

VL - 117

SP - 84

EP - 92

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -